Page 110 - Read Online

Orekhov et al. Vessel Plus 2019;3:10 I http://dx.doi.org/10.20517/2574-1209.2019.04 Page 15 of
20
cells. J Exp Med 2007;204:171-80.
8. Carlin LM, Stamatiades EG, Auffray C, Hanna RN, Glover L, et al. Nr4a1-dependent Ly6C(low) monocytes monitor endothelial cells
and orchestrate their disposal. Cell 2013;153:362-75.
9. Arnold L, Henry A, Poron F, Baba-Amer Y, van Rooijen N, et al. Inflammatory monocytes recruited after skeletal muscle injury switch
into anti-inflammatory macrophages to support myogenesis. J Exp Med 2007;204:1057-69.
10. Hanna RN, Carlin LM, Hubbeling HG, Nackiewicz D, Green AM, et al. The transcription factor NR4A1 (Nur77) controls bone marrow
differentiation and the survival of Ly6C- monocytes. Nat Immunol 2011;12:778-85.
11. Varga T, Mounier R, Gogolak P, Poliska S, Chazaud B, et al. Tissue LyC6- macrophages are generated in the absence of circulating
LyC6- monocytes and Nur77 in a model of muscle regeneration. J Immunol 2013;191:5695-701.
12. Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol 2014;5:514.
13. Ziegler-Heitbrock L, Ancuta P, Crowe S, Dalod M, Grau V, et al. Nomenclature of monocytes and dendritic cells in blood. Blood
2010;116:e74-80.
14. Ziegler-Heitbrock L. Monocyte subsets in man and other species. Cell Immunol 2014;289:135-9.
15. Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol 2008;8:533-44.
16. Fleetwood AJ, Lawrence T, Hamilton JA, Cook AD. Granulocyte-macrophage colony-stimulating factor (CSF) and macrophage CSF-
dependent macrophage phenotypes display differences in cytokine profiles and transcription factor activities: implications for CSF
blockade in inflammation. J Immunol 2007;178:5245-52.
17. Jaguin M, Houlbert N, Fardel O, Lecureur V. Polarization profiles of human M-CSF-generated macrophages and comparison of M1-
markers in classically activated macrophages from GM-CSF and M-CSF origin. Cell Immunol 2013;281:51-61.
18. Chistiakov DA, Bobryshev YV, Orekhov AN. Changes in transcriptome of macrophages in atherosclerosis. J Cell Mol Med
2015;19:1163-73.
19. Gleissner CA, Shaked I, Erbel C, Böckler D, Katus H, et al. CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in
human macrophages. Circ Res 2010;106:203-11.
20. Gleissner CA. Macrophage phenotype modulation by CXCL4 in atherosclerosis. Front Physiol 2012;3:1.
21. Ferrante CJ, Leibovich SJ. Regulation of macrophage polarization and wound healing. Adv Wound Care (New Rochelle) 2012;1:10-6.
22. Ferrante CJ, Pinhal-Enfield G, Elson G, Cronstein BN, Hasko G, et al. The adenosine-dependent angiogenic switch of macrophages to
an M2-like phenotype is independent of interleukin-4 receptor alpha (IL-4Rα) signaling. Inflammation 2013;36:921-31.
23. Chistiakov DA, Bobryshev YV, Nikiforov NG, Elizova NV, Sobenin IA, et al. Macrophage phenotypic plasticity in atherosclerosis: the
associated features and the peculiarities of the expression of inflammatory genes. Int J Cardiol 2015;184:436-45.
24. Sica A, Erreni M, Allavena P, Porta C. Macrophage polarization in pathology. Cell Mol Life Sci 2015;72:4111-26.
25. Huen SC, Cantley LG. Macrophage-mediated injury and repair after ischemic kidney injury. Pediatr Nephrol 2015;30:199-209.
26. Murray PJ, Allen JE, Biswas SK, Fisher EA, Gilroy DW, et al. Macrophage activation and polarization: nomenclature and experimental
guidelines. Immunity 2014;41:14-20.
27. Saha B, Jyothi Prasanna S, Chandrasekar B, Nandi D, et al. Gene modulation and immunoregulatory roles of interferon gamma.
Cytokine 2010;50:1-14.
28. Totzke G, Essmann F, Pohlmann S, Lindenblatt C, Jänicke RU, et al. A novel member of the IkappaB family, human IkappaB-zeta,
inhibits transactivation of p65 and its DNA binding. J Biol Chem 2006;281:12645-54.
29. Weiss M, Blazek K, Byrne AJ, Perocheau DP, Udalova IA, et al. IRF5 is a specific marker of inflammatory macrophages in vivo.
Mediators Inflamm 2013;2013:245804.
30. El Kasmi KC, Smith AM, Williams L, Neale G, Panopoulos AD, et al. Cutting edge: a transcriptional repressor and corepressor induced
by the STAT3-regulated anti-inflammatory signaling pathway. J Immunol 2007;179:7215-9.
31. Gratchev A, Kzhyshkowska J, Kannookadan S, Ochsenreiter M, Popova A, et al. Activation of a TGF-beta-specific multistep gene
expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J Immunol
2008;180:6553-65.
32. Hansen G, Hercus TR, McClure BJ, Stomski FC, Dottore M, et al. The structure of the GM-CSF receptor complex reveals a distinct
mode of cytokine receptor activation. Cell 2008;134:496-507.
33. Krausgruber T, Blazek K, Smallie T, Alzabin S, Lockstone H, et al. IRF5 promotes inflammatory macrophage polarization and TH1-
TH17 responses. Nat Immunol 2011;12:231-8.
34. Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, et al. Gene expression profiling during differentiation of human
monocytes to macrophages or dendritic cells. J Leukoc Biol 2007;82:710-20.
35. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular
signaling proteins. Science 1994;264:1415-21.
36. Shuai K, Ziemiecki A, Wilks AF, Harpur AG, Sadowski HB, et al. Polypeptide signalling to the nucleus through tyrosine
phosphorylation of Jak and Stat proteins. Nature 1993;366:580-3.
37. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal
transduction. J Biol Chem 1999;274:10689-92.
38. Steen HC, Gamero AM. The role of signal transducer and activator of transcription-2 in the interferon response. J Interferon Cytokine
Res 2012;32:103-10.
39. Stark GR, Kerr IM, Williams BR, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998;67:227-64.